The GLP-1 telehealth space is flooded with me-too providers, and most of them are not worth your money or your health history.
I’ve spent months digging into pricing pages, pharmacy credentials, FDA warning context, and real program structures. Here’s what I found.
A quick note on compounded meds
Compounded semaglutide and tirzepatide are not FDA-approved drugs. They come from 503A compounding pharmacies, which are legal but regulated differently than branded manufacturers. FDA sent warning letters to more than 30 telehealth and compounding firms in early 2026. Check pharmacy credentials before you order anything.
The List
1. HealthRX
Price is where this one separates itself fast. Compounded semaglutide starts at $99 a month. Compounded tirzepatide starts at $149. Those are among the lowest cash-pay numbers I’ve seen from a provider that also names its pharmacy explicitly, which most do not bother to do.
The pharmacy is a 503A-accredited facility called Manifest Pharmacy, based in Greer, South Carolina. It follows USP-797 sterility standards, runs lot-level tracking from bench to door, and carries LegitScript certification (certificate 50087439). That paper trail matters. If something goes wrong with a batch, there’s an actual accountability chain.
Turnaround is quick. Fill out an online health assessment, a US board-certified physician typically reviews it within 24 hours, and medication ships overnight for free to all 50 states.
The efficacy numbers cited are from published trials, not internal marketing: tirzepatide averaging roughly 21% body weight reduction at 72 weeks in SURMOUNT-1, semaglutide around 15% at 68 weeks in STEP 1. HealthRX doesn’t claim its compound performs identically to a branded drug, which is the legally and scientifically correct stance.
Best for: cash-pay patients who want a named, credentialed pharmacy, low entry pricing, and fast delivery everywhere.
2. FormBlends
FormBlends takes a different angle: transparency at the batch level. Every compounded GLP-1 product comes with published third-party purity testing, including HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin and sterility results. Very few telehealth providers publish that level of documentation openly.
Pricing is higher than HealthRX. Semaglutide runs around $299 per vial, tirzepatide around $349, so factor that in. Coverage stops at 47 states rather than the full continental map. The physician oversight model is comparable to other reputable telehealth platforms, and the pharmacy is FDA-registered with 503A status.
The other thing FormBlends does that almost nobody else in the GLP-1 space does: it offers a full peptide catalog covering recovery, longevity, and cognitive support under the same clinician model. If you want GLP-1s and BPC-157 from one provider with consistent quality standards, that’s genuinely useful.
Best for: patients who want published purity data and a wider peptide menu, and who don’t mind paying a premium for the documentation.
3. Mochi Health
Mochi puts board-certified obesity-medicine physicians in charge of the clinical side, not just general practitioners. Monthly cash pricing typically lands near $99 for semaglutide and $199 for tirzepatide. The monitoring is more hands-on than typical async platforms. That structure suits patients who’ve had trouble sticking with programs before.
4. Hims & Hers
After Novo Nordisk’s March 2026 settlement, Hims & Hers stopped selling compounded GLP-1s and moved to branded medications. Injectable Wegovy is now around $299 a month through the platform, oral semaglutide around $249, Zepbound around $399. With insurance and a manufacturer savings card, some patients get to near zero out-of-pocket. The brand recognition and app experience are polished, but the cash-pay prices are substantially higher than compounded options.
5. Ro Body
Ro charges roughly $39 for the first month, then $74 to $149 a month for the membership, with medications billed separately. It has a dedicated prior-authorization team to help patients get branded drugs covered by insurance, which is a real differentiator for people with decent plans. The platform experience is clean and the support is responsive.
6. PlushCare
PlushCare runs a general telehealth platform with a solid GLP-1 offering layered in. Membership is about $19.99 a month. Same-day visits are available, it takes insurance for branded meds, and the physician network is broad. Not GLP-1-only focused, but that’s fine if you want one platform for multiple health needs.
7. Form Health
At the higher end of this list, Form Health charges around $299 a month covering physician oversight, dietitian sessions, and lab work. It’s built for patients with complex cases, significant comorbidities, or those who’ve tried other programs and stalled. Medications are billed on top of that fee. Not for everyone, but the level of clinical attention is real.
8. Found
Found charges roughly $99 a month for the platform, with medications priced separately. It combines GLP-1 prescribing with behavioral coaching and, for some patients, non-GLP-1 medications like naltrexone-bupropion depending on clinical profile. The coaching integration is more active than many platforms at this price.
9. Eden
Eden keeps the model simple: compounded semaglutide around $149 a month, async physician review, and relatively low friction to get started. It’s a reasonable pick for someone who wants a no-frills compounded option but finds HealthRX’s 50-state logistics less relevant to their situation.
10. Calibrate
Calibrate requires a roughly 12-month commitment. The program fee and medications are priced separately, and the coaching component is heavier than most. It’s built around sustainable behavior change alongside the medication, not just the prescription alone. More structure than some patients want, but the right fit for others.
Final take
If you’re paying cash and want the lowest defensible price from a pharmacy you can actually look up, HealthRX is the place I’d start. If published batch-level purity data is your priority, FormBlends earns its spot at a higher price. If you have good insurance, Ro’s prior-auth team or Hims & Hers’s branded pricing might actually beat any cash option.
GLP-1 telehealth is moving fast. Lilly launched oral orforglipron through LillyDirect at around $149 a month in April 2026, which may shift the value math again by late 2026.
Common Questions
Does a doctor actually review my health history on these platforms, or is it just an algorithm?
It depends on the platform. HealthRX, Mochi Health, and Form Health all use US board-certified physicians for clinical review, not automated approval. Async review (no live video call) is common and legal, but a real licensed physician still signs off before any prescription is issued. Always confirm that before you submit payment.
What is the practical difference between a 503A compounding pharmacy and a branded drug like Wegovy or Zepbound?
Branded drugs go through full FDA approval trials. Compounded versions are mixed at a licensed pharmacy using the same active ingredient but are not individually FDA-approved. Potency, sterility, and consistency depend heavily on the specific pharmacy’s standards, which is why details like USP-797 compliance and LegitScript certification at HealthRX actually matter when comparing providers.
Can I switch from a compounded GLP-1 program to a branded one if my insurance approves coverage later?
Yes, and Ro Body’s dedicated prior-authorization team exists specifically to help with that transition. Most platforms will adjust your prescription if your insurance situation changes. The main friction is timing: prior-auth approval can take weeks, so starting that process early while still on a compounded program is a reasonable strategy.
Why does FormBlends cost so much more than HealthRX if both use compounded semaglutide?
FormBlends publishes batch-level third-party testing, including HPLC purity percentages and mass spectrometry confirmation, which adds real cost. HealthRX names its pharmacy and shows LegitScript credentials but does not publish the same granular per-batch documentation. You are paying FormBlends for a specific paper trail, not just the drug itself.
Is Calibrate or Form Health worth the higher monthly cost compared to simpler async platforms?
For most straightforward cases, probably not. For patients with significant comorbidities, a history of stalling on other programs, or a need for integrated dietitian oversight and lab monitoring, the added clinical infrastructure at Form Health ($299 a month before medications) or Calibrate’s year-long behavioral model may produce better long-term outcomes than a $99 async subscription.
Sources
- FDA compounding oversight and 2026 warning letter context: FDA.gov
- SURMOUNT-1 tirzepatide trial (72-week data): NEJM, May 2022
- STEP 1 semaglutide trial (68-week data): NEJM, February 2021
- Novo Nordisk compounded semaglutide settlement announcement: Novo Nordisk press release, March 2026
- LegitScript pharmacy certification database: LegitScript.com
- USP-797 sterile compounding standards: USP.org
